Live Webinar | October 28, 2026
To centralize or to decentralize, that is the question!
LIVE WEBINAR | October 28, 2026 | This webinar explores the clinical, operational, and financial considerations of centralizing versus decentralizing molecular infectious disease testing, including impacts on turnaround time, workflow, diagnostic performance, and patient care. (1 credit)
- Wednesday, October 28, 2026
- 1:00 PM EST / 12:00 PM CST
- Dr. Kenneth Gavina, Ph.D.
- 1 hour
- 1 credit
- Supported by ZeptoMetrix
- Free
Summary
Date: October 28, 2026 | 1:00 PM EST / 12:00 PM CST
Duration: 1 Hour
Credits: 1
Presenter: Dr. Kenneth Gavina, Ph.D., D(ABMM), SM(ASCP)
Sponsor: ZeptoMetrix
Cost: Free
As molecular tools continue to evolve and become the gold standard methodology in the clinical lab, the landscape of where infectious disease testing should be performed becomes blurred and challenging. This webinar will explore the clinical, operational, and financial considerations of centralizing versus decentralizing molecular testing for infectious diseases. Topics will include turnaround time, test utilization, laboratory workflow, and the impact of testing location on diagnostic performance and patient care.
Learning Objectives
At the conclusion of this webinar, participants will be able to:
- Describe advantages and disadvantages of centralized vs. decentralized molecular testing.
- Review regulatory and QC challenges with decentralized testing.
- Discuss potential clinical utility, improved patient outcomes, and health-system value of decentralized testing.
Presented by
Dr. Kenneth Gavina, Ph.D., D(ABMM), SM(ASCP)
Indiana University School of Medicine
Dr. Kenneth Gavina is an assistant professor of clinical pathology at Indiana University School of Medicine, the Director of Clinical Microbiology & Serology for Eskenazi Health, and the Associate Medical Director for Molecular Infectious Disease Testing at IU Health in Indianapolis, IN. His research interests include diagnostic stewardship, molecular diagnostics and next-generation sequencing, novel assay development, and point-of-care testing for infectious diseases in low-resource settings.
Supported in part through an unrestricted educational grant by:
Level of Instruction: Intermediate
Medical Laboratory Observer (MLO) is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program.
